Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q57601805)
Watch
English
Significant clinical worsening after natalizumab withdrawal: Predictive factors
article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25392320
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25392320%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
title
Significant clinical worsening after natalizumab withdrawal: Predictive factors
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25392320
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25392320%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
author
Angela Vidal-Jordana
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25392320
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25392320%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
Mar Tintoré
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25392320
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25392320%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
Carmen Tur
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25392320
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25392320%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
Francisco Pérez-Miralles
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25392320
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25392320%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
Jordi Rio
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25392320
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25392320%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
Georgina Arrambide
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25392320
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25392320%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
Ingrid Galán
series ordinal
10
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25392320
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25392320%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
Jaume Sastre Garriga
series ordinal
12
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25392320
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25392320%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
Xavier Montalban
series ordinal
14
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25392320
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25392320%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
author name string
C Auger
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25392320
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25392320%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
C Nos
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25392320
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25392320%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
M Comabella
series ordinal
9
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25392320
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25392320%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
J Castilló
series ordinal
11
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25392320
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25392320%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
A Rovira
series ordinal
13
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25392320
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25392320%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
publication date
12 November 2014
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25392320
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25392320%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
published in
Multiple Sclerosis Journal
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25392320
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25392320%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
volume
21
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25392320
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25392320%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
issue
6
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25392320
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25392320%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
page(s)
780-785
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25392320
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25392320%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
cites work
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1177%2F1352458514549401
retrieved
21 January 2018
Natalizumab: bound to rebound?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1177%2F1352458514549401
retrieved
21 January 2018
De-escalation from natalizumab in multiple sclerosis: recurrence of disease activity despite switching to glatiramer acetate.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1177%2F1352458514549401
retrieved
21 January 2018
Reduction of the washout time between natalizumab and fingolimod.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1177%2F1352458514549401
retrieved
21 January 2018
Identifiers
DOI
10.1177/1352458514549401
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25392320
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25392320%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
PubMed publication ID
25392320
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25392320
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25392320%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit